Structured evidence table for Gamma Oryzanol Lipids Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Gamma Oryzanol Lipids Randomized Trial | Background Diabetes mellitus (DM) and associated complications remain a global public health challenge despite many confrontational aspects of the disease, and its prevalence is projected to rise in the coming decades. | 1 | Radda MI (2025) | Effectiveness of gamma-oryzanol in glycaemic control and managing oxidative stress, inflammation, and dyslipidaemia in diabetes: a systematic review of preclinical studies. |
| Gamma Oryzanol Lipids Randomized Trial | Increasing evidence from the scientific literature has revealed the beneficial effects of gamma oryzanol for treating diabetes and its related complications. | 1 | Radda MI (2025) | Effectiveness of gamma-oryzanol in glycaemic control and managing oxidative stress, inflammation, and dyslipidaemia in diabetes: a systematic review of preclinical studies. |
| Gamma Oryzanol Lipids Randomized Trial | SyCLE's risk of bias tool was used to assess the methodological quality of the studies. | 1 | Radda MI (2025) | Effectiveness of gamma-oryzanol in glycaemic control and managing oxidative stress, inflammation, and dyslipidaemia in diabetes: a systematic review of preclinical studies. |
| Gamma Oryzanol Lipids Randomized Trial | Thus, there is an urgent need to intensify the current efforts to address both the prevalence and adverse effects of diabetes, including the use of natural products. | 1 | Radda MI (2025) | Effectiveness of gamma-oryzanol in glycaemic control and managing oxidative stress, inflammation, and dyslipidaemia in diabetes: a systematic review of preclinical studies. |
| Gamma Oryzanol Lipids Randomized Trial | Diets high in simple carbohydrates and saturated fats increase the risk of liver diseases. | 4 | Siqueira JS (2025) | Gamma oryzanol modulates hepatic lipids expression and regulates integrated pathways in liver disease pathophysiology under a high sugar fat diet. |
| Gamma Oryzanol Lipids Randomized Trial | Gamma oryzanol (ORY), a compound found in rice bran, shows promise in addressing metabolic liver diseases, though its impact on lipid pathways requires further exploration. | 4 | Siqueira JS (2025) | Gamma oryzanol modulates hepatic lipids expression and regulates integrated pathways in liver disease pathophysiology under a high sugar fat diet. |
| Gamma Oryzanol Lipids Randomized Trial | This study evaluated the effects of ORY in rats submitted to a high sugar-fat (HSF) diet using a multiomics approach to unravel its impact on lipid metabolism and associated pathways. | 4 | Siqueira JS (2025) | Gamma oryzanol modulates hepatic lipids expression and regulates integrated pathways in liver disease pathophysiology under a high sugar fat diet. |
Source documents